Federal investment in medical research and the biomedical research workforce is a and the beginning of hope for patients suffering from serious illnesses like cancer, diabetes, Alzheimer’s disease, depression, and Parkinson’s disease. By far the largest source of federal research funding comes from the National Institutes of Health (NIH). In fact, nearly 55 percent of all extramural research (grants to outside scientists) sponsored by the NIH is conducted at AAMC-member medical schools and teaching hospitals. NIH-funded research has pioneered many of the advances that help all Americans live longer, healthier lives. This partnership has resulted in from reduced mortality from heart disease and stroke to more precise ways to diagnose and treat cancers.
NIH-funded research conducted at the nation’s medical schools and teaching hospitals has led to a deeper understanding of the mechanisms of human health and disease and has provided better diagnostics, treatments, cures, and ways to improve health and save lives. Continued advances require sustaining robust, predictable increases in the NIH budget.
Though strong bipartisan support in Congress has led to significant recent funding increases, NIH’s budget—adjusted for inflation—remains lower than it was a decade ago, while the health challenges and complexity of medical research have increased.
In addition, medical discovery and advancement requires effective research across a continuum from basic science to clinical, health services, and health systems research.
While the country faces enormous economic challenges, When considering the many different solutions to restore the nation’s fiscal health, lawmakers should work together toward a solution that guarantees sustained, predictable real growth in federal support for medical research funded by the NIH..
It is also vital to support research, health agencies, and initiatives across the spectrum. These include the Centers for Disease Control and Prevention (CDC), the Agency for Healthcare Research and Quality (AHRQ), the Health Resources and Services Administration (HRSA), the National Science Foundation (NSF), the Department of Veterans Affairs (VA), and the Patient-Centered Outcomes Research Institute (PCORI).
Research at Medical Schools and Teaching Hospitals
Medical schools and teaching hospitals are the only places in the health care system where medical research, doctor education and training, and patient care come together.
Economic Benefits of Medical Research
Federal- and state-funded research conducted at the nation's medical schools and teaching hospitals contribute $25.4 billion in total GDP and over 300,000 jobs to the U.S. economy, according to a study conducted for the AAMC by RTI.
National MD-PhD Programs Outcomes Study
Thetracks the careers of MD-PhD dual-degree program graduates over 50 years (1964–2014) and highlights results of a research project that explored their career paths.
Ad Hoc Group for Medical Research
The is a coalition of more than 300 patient and voluntary health groups, medical and scientific societies, academic and research organizations, that supports enhancing the federal investment in the biomedical research conducted and funded by the National Institutes of Health (NIH).
An infographic explaining how sustained, meaningful growth in the National Institutes of Health (NIH) budget, and the research at medical schools and teaching hospitals that it funds, is an investment that results in saved lives, better health, economic growth, stronger local and regional economies, and U.S. global leadership in science and technology.
(September 26, 2018)
AAMC President and CEO Darrell G. Kirch, MD, issued a statement regarding House passage of the conference agreement on the fiscal year 2019 appropriations for the Departments of Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS).
(September 18, 2018)
AAMC President and CEO Darrell G. Kirch, MD, issued this statement regarding Senate passage of the conference agreement on the fiscal year 2019 appropriations for the Departments of Labor, Health and Human Services, Education, and Related Agencies.
(August 1, 2018)
AAMC President and CEO Darrell G. Kirch, MD, issued a statement regarding President Trump’s announcement that he intends to nominate Kelvin Droegemeier, PhD, to be the next director of the White House Office of Science and Technology Policy (OSTP):
(June 29, 2018)
AAMC President and CEO Darrell G. Kirch, MD, issued a statement on the FY 2019 Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) spending bill approved yesterday by the Senate Committee on Appropriations.
The AAMC, in association with the Ad Hoc Group for Medical Research and other organizations from the patient, provider, scientific, and academic communities, held a Capitol Hill Reception in the Kennedy Caucus Room on June 20 to celebrate the life-saving achievements in biomedical innovation supported by the NIH and to thank Members of Congress for their meaningful, sustained commitment to the NIH.
(June 14, 2018)
AAMC President and CEO Darrell G. Kirch, MD, issued a statement on the draft FY 2019 spending bill released today by the House Appropriations Subcommittee on Labor, Health and Human Services, and Education and Related Agencies.